SPT — AGM Information 2019

Jul 16, 2019

ScinoPharm Taiwan, Ltd.

Meeting Notice of

2019 Annual General Shareholders’ Meeting

(Summary Translation)

The 2019 Annual General Shareholders’ Meeting (the “Meeting”) of ScinoPharm Taiwan, Ltd. (the “Company”) will be convened at 9:30 a.m., Thursday, June 27, 2019 at ScinoPharm Taiwan, Ltd. Administration Building (1F, 1 Nan-Ke 8[th] Road, Southern Taiwan Science Park, Shan-Hua, Tainan, Taiwan).

1. The agenda for the Meeting is as follows:

   • I. Report Items

     • (1) 2018 Business Report.

     • (2) Audit Committee’s Review Report on 2018 Financial Results.

     • (3) 2018 Compensations for Employees and Directors.

   • II. Ratification Items

     • (1) Ratification of 2018 Business Report and Financial Statements.

     • (2) Ratification of the Proposed Distribution of 2018 Earnings.

   • III. Discussion Items

     • (1) Proposed Amendment to the Articles of Incorporation of the Company.

     • (2) Proposed Amendment to the Procedures for Acquisition and Disposal of Assets of the Company.

     • (3) Proposed release of Director’s Non-Compete Restrictions.

   • IV. Extemporary motions

2. Proposal for distribution of 2018 profits has been resolved by the Board of Directors as follows:

   • Cash dividends: Totaling NT$387,462,219, the proposed dividends is NT$0.49 per share. Upon the approval of Annual Meeting of Shareholders, it is proposed that the Board of Directors be authorized to resolve the ex-dividend date.

3. Pursuant to Article 165 of the Company Act, the Company hereby closes the share transfer registration from April 29, 2019 to June 27, 2019.

4. If any shareholder solicits for a proxy, the Company will disclose the summarization of the solicitation prepared by the Company on the website of the Securities and Futures Institute (http://free.sfi.org.tw) on May 27, 2019. If any investor wishes to make inquiries, please log into the “free inquiry system for published information of proxy” on the website, and click the right side “entrance to published information of proxy” and input the key words for the inquiry.

5. The shareholder’s voting power of this annual shareholders' meeting may be exercised by way of electronic transmission, and the exercising period will be from May 28[th] , 2019 through June 24[th] , 2019. Please log in the “Stockvote” established by Taiwan Depository & Clearing Corporation at http://www.stockvote.com.tw.

6. The institution for tallying and verifying proxy forms of 2019 general shareholders’ meeting is Stock Registration Department, President Securities Corporation.

7. If there exist any matters that shall be itemized in the causes and the essential contents thereof shall be explained pursuant to Article 172 of the Company Law, the essential contents can be found at the Market Observation Post System (http://mops.twse.com.tw). Please log into said website, and click “electronic books”, key in the Year “2019,” select the code of the Company “1789,” and read references related to the shareholders’ meeting.

Board of Directors ScinoPharm Taiwan, Ltd.